Skip to main content

Table 3 Comparison of outcomes for patients who successfully suppressed viremia to <1000cp/ml with patients who were unable to suppress viral replication while on treatment

From: Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort

  Suppressed (n = 41) Never suppressed (n = 48)
Gender:   
Male 23 30
At initiation:   
Age, years, median (IQR) 6.9 (4.4-9.8) 7.1 (3.2-9.6)
Viral load, log10 cp/ml, median (IQR) 3.8 (3.4-4.7) 4.2 (3.7-4.7)
CD4, cells/μl, median (IQR) 290 (136–563) 281 (89–560)
Regimen   
3TC-D4T-EFV 33 31
3TC-D4T-LPV/r 6 6
3TC-ABC-EFV 1 7
3TC-ABC-LPV/r 0 4
3TC-AZT-EFV 1 0
At genotyping:   
Age, years, median (IQR)* 11.1 (8.5-13.1) 9.8 (5.6-12.3)
  1. Key: *Statistical significance (T-test, P<0.05).